At every time point measured the cohort of SRP9001 treated participants outperformed the placebo group and at 48 weeks participants in the treatment group demonstrated a statistically significant increase of 17 points in NSAA total score compared to baseline P0009 while participants in the placebo group saw an increase of 09 points on the NSAA total score compared to baseline which was not statistically significant n21 P01411